ARCHIVES

Major Emphasis Switch; Outreach Core Support Ends In Favor Of Cancer Control Research

This article is from The Cancer Letter archive.

Vol. 08 No. 04 | January 22, 1982

Download PDF Visit The Full Archive

Related Articles

Report: Rising Treatment Costs Due to 340B Discounts

May 16, 2014

New Biologic Therapies Showing Promise In A Variety Of Advanced Solid Tumors

June 29, 2001

NCI To require Prompt Publication Of Data Affected By Falsification In Future Grants

April 8, 1994

Murray Copeland Display Dedicated

March 18, 1983

Rituxan Approved as Maintenance For Advanced Follicular Lymphoma

February 25, 2011

Zaltrap Economics 101: The Pricing And Repricing of an Expensive Drug

November 16, 2012